Market Place
Sourcing Support
Early sales of Lilly’s obesity pill appear to trail Novo’s
01 May 2026 //
ENDPOINTS
Boehringer, Zealand`s Obesity Drug Resembles Novo`s Wegovy
29 Apr 2026 //
BIOSPACE
Novo Nordisk at ECO: Wegovy & Next-Gen Weight Loss Treatments
28 Apr 2026 //
GLOBENEWSWIRE
Novo Eyes Adolescent Diabetes Approval for Oral Semaglutide
27 Apr 2026 //
FIERCE PHARMA
Novo`s Etavopivat Meets Both Endpoints in Sickle Cell Disease
20 Apr 2026 //
GLOBENEWSWIRE
Wegovy-maker Novo Nordisk partners with OpenAI
16 Apr 2026 //
REUTERS
MHRA Approves Single-Dose Injection Device For Wegovy 7.2Mg
14 Apr 2026 //
PHARMIWEB
Retatrutide Ignites Buzz on Weight Loss, Longevity
13 Apr 2026 //
ECONOMICTIMES
Novo Nordisk launches higher-dose Wegovy in the United States
10 Apr 2026 //
PRNEWSWIRE
Novo`s Wegovy: First EU-Approved GLP-1 for 48-Week Use
09 Apr 2026 //
GLOBENEWSWIRE
After $2.1B Novo Deal, Vivtex Is Just Getting Started
08 Apr 2026 //
FIERCE BIOTECH
Diabetes Drug Fuels Growing Weight Loss Trend in India
07 Apr 2026 //
INDPHARMAPOST
Anthropic Puts $400M Into Coefficient Bio Life Sciences
06 Apr 2026 //
BIOSPACE
Wegovy Pill Shows Greater Weight Loss vs Orforglipron: Analysis
02 Apr 2026 //
PR NEWSWIRE
In Deal Fraud Dispute With Novo, KBP Looks To Revive Heart Drug
01 Apr 2026 //
FIERCE BIOTECH
Novo`s long-acting insulin Awiqli wins FDA nod
28 Mar 2026 //
PR NEWSWIRE
Novo Nordisk Triple Agonist UBT251 Cuts HbA1c by 2.16% in Phase 2
25 Mar 2026 //
GLOBENEWSWIRE
Lexicon, Novo Launch Oral LX9851 Phase 1 Obesity Trial
23 Mar 2026 //
GLOBENEWSWIRE
Roche Halts SMA Drug, Boosting Rivals` Prospects
20 Mar 2026 //
BIOSPACE
FDA Approves Wegovy HD to Maximize Weight Loss
20 Mar 2026 //
PR NEWSWIRE
North Carolina Attracts Amgen, Roche For Next-Gen Obesity Drug
03 Mar 2026 //
BIOSPACE
Novo, Vivtex in up to US$2.1 bn Obesity Deal
27 Feb 2026 //
GLOBENEWSWIRE
Lilly Tops Novo In Weight Loss Again, This Time On The Oral Front
26 Feb 2026 //
BIOSPACE
Novo`s UBT251 Hits 19.7% Weight Loss in China Phase 2 Trial
25 Feb 2026 //
GLOBENEWSWIRE
Novo`s CagriSema Trial Deals Blow in Obesity drug Battle Lilly
24 Feb 2026 //
REUTERS
Madrigal Embraces Novo Competition As MASH Drug Gains Steam
19 Feb 2026 //
FIERCE PHARMA
Oral Wegovy Brings In Thousands Of New GLP-1 Patients
12 Feb 2026 //
BIOSPACE
Amylin`s Oral Obesity Assets Gain Momentum In 2026
06 Feb 2026 //
BIOSPACE
The Biggest Potential Drug Launches Of 2026
06 Feb 2026 //
FIERCE PHARMA
Novo`s Cagrisema Tops Semaglutide In Ph. 3 Diabetes Study
02 Feb 2026 //
FIERCE BIOTECH
New Consortium Transforms Antibiotic Discovery to Counter AMR
22 Jan 2026 //
PR NEWSWIRE
Novo Expands Diabetes Cell Therapy Partnership with Aspect Bio
21 Jan 2026 //
REUTERS
Novo Foundation Invests $860M To Nurture Homegrown Biotechs
15 Jan 2026 //
FIERCE BIOTECH
Pfizer Expedites Obesity Programs Amid Patent Cliff Challenge
13 Jan 2026 //
BIOSPACE
JPM: Novo CSO Craves `Different Flavors` Of Pipeline Innovation
13 Jan 2026 //
FIERCE BIOTECH
Biotech Showcase Facilitates Investor, Pharma, And Media Access
08 Jan 2026 //
PHARMIWEB
EMED Enables WEGOVY PILL ACCESS Via Clinical CARE MODEL
06 Jan 2026 //
PR NEWSWIRE
Novo launches Wegovy pill in US from $149 per month for patients
05 Jan 2026 //
REUTERS
Novo`s GLP-1 Failure Sparks Alzheimer`s Combination Opportunity
02 Jan 2026 //
BIOSPACE
Novo Files Marketing Application For Next-gen Weight-Loss Drug
22 Dec 2025 //
REUTERS
Novo`s Oral Semaglutide Is PCPs` Most-Anticipated Obesity Med
15 Dec 2025 //
FIERCE PHARMA
Novo Nordisk: efficacious dose of Wegovy recommended by theEMA
12 Dec 2025 //
GLOBENEWSWIRE
Lilly, Novo Pricing Strategies Set Stage For Future Competition
03 Dec 2025 //
BIOSPACE
Novo Nordisk Justifies Reasoning Behind Failed GLP-1 Alzheimer
02 Dec 2025 //
REUTERS
Novo Nordisk Seeks FDA Approval for Higher 7.2mg Wegovy Dose
26 Nov 2025 //
PR NEWSWIRE
Novo Expands Pivotal Program After Amycretin Shines in Diabetes
25 Nov 2025 //
GLOBENEWSWIRE
Novo Reports 2 Trial Failures For GLP-1 In Alzheimer`s Disease
24 Nov 2025 //
GLOBENEWSWIRE
Biogen`s Leqembi Rises After Novo GLP-1 Fails In Alzheimer
24 Nov 2025 //
BIOSPACE
Korro Lays Off Staff As Lead Drug Disappoints, Novo Pauses Pact
13 Nov 2025 //
FIERCE BIOTECH
Search For Next Blockbuster Drug Extends Beyond Weight Loss
10 Nov 2025 //
BIOSPACE
Pfizer wins $10 billion bidding war for Metsera as Novo Exist
08 Nov 2025 //
REUTERS
Novo Nordisk`s Cagrisema Reduces Blood Pressure
06 Nov 2025 //
PR NEWSWIRE
Novo Drops Oncology Ambitions, Early-Stage MASH Prospects
05 Nov 2025 //
FIERCE BIOTECH
Novo Nordisk to Unveil Wegovy 2.4mg Data at AASLD Meeting
28 Oct 2025 //
PR NEWSWIRE
Novo Nordisk To Unveil Oral Semaglutide 25mg Data at ObesityWeek
20 Oct 2025 //
PR NEWSWIRE
FDA Approves Novo`s oral semaglutide For Cardiovascular Risk
17 Oct 2025 //
PR NEWSWIRE
Novo Strikes Up To $5.2B Deal For Akero In Red-Hot MASH Space
11 Oct 2025 //
BIOSPACE
Novo Ends All Cell Therapy R&D, Lets Go Of Staff
10 Oct 2025 //
FIERCE BIOTECH
Biomea Fusion Shows Icovamenib Improves Blood Sugar In T2D
07 Oct 2025 //
EXPRESSPHARMA
Skye`s CB1 Blocker Fails To Reduce Weight In Obesity Study
06 Oct 2025 //
FIERCE BIOTECH
